MONOVALENT TICK FEVER VACCINE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

BABESIA BOVIS

Available from:

DEPARTMENT OF AGRICULTURE AND FISHERIES

INN (International Name):

Babesia bovis(10000000u/dose)

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

BABESIA BOVIS VACCINE-MICROBIAL Active 0.0 Undefined

Units in package:

20-200mL

Class:

VM - Veterinary Medicine

Manufactured by:

DEPT AGRICULTURE, FI

Therapeutic group:

CALF | BEEF CALF | BOVINE | CALF - PODDY | CALF - PREWEANING | CALF - SUCKER | DAIRY CALF | NEONATAL CALF

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

TICK FEVER - BOVINE BABESIOSIS | VACCINE | BABESIA BIGEMINA | BABESIA BOVIS | EQUINE ROTAVIRUS | RED WATER | REDWATER

Product summary:

Poison schedule: 0; Withholding period: WHP:N/A; Host/pest details: CALF: [TICK FEVER - BOVINE BABESIOSIS, VACCINE]; For control of tick fever (Babesiosis) in cattle.Caution: Avoid carcass damage. See PRECAUTIONS, etc. on label also.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

FOR ANIMAL TREATMENT ONLY
_MONOVALENT TICK FEVER VACCINE_
_Contains B bovis 1 x 10_
_7 _
_organisms per dose_
FOR CONTROL OF TICK FEVER IN CATTLE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
If accidental self-injection occurs, seek medical advice
Dose: 2mL. For subcutaneous or intramuscular injection
WITHHOLDING PERIOD NIL
EXPIRY DATE:
B
Store between 2°C to 8°C (Refrigerate. DO NOT FREEZE)
Tick Fever Centre,
280 Grindle Rd, Wacol, QLD 4076
File name
41156_4507 8_20-200mL_immediate_MPL_V02.pdf
Dimensions
95mm X 50mm
Scale
100%
Date
21/05/08 V02
PANTONE 288
PANTONE 1505
APVMA
41156/20–200mL/0508
20–200mL
MON 010–100
APPROVED
LABEL
Info
PEST


Verified
FOR ANIMAL TREATMENT ONLY
MONOVALENT TICK FEVER VACCINE
MONOVALENT VACCINE CONTAINS:
_BABESIA BOVIS_ 1 X 10
7 ORGANISMS PER DOSE
FOR CONTROL OF TICK FEVER
(BABESIOSIS) IN CATTLE
This vaccine contains a live attenuated strain of _Babesia _
_bovis_. One vaccination is usually sufficient to provide
life long immunity against _Babesia bovis _field infection.
Immunity develops within 3 weeks of administration of
the vaccine.
_This vaccine is registered with the Australian Pesticides _
_and Veterinary Medicines Authority (Reg. No 41156) _
_and is manufactured in compliance with the Australian _
_Code of Good Manufacturing Practice for Veterinary _
_Preparations._
TICK FEVER CENTRE
280 GRINDLE RD.,
WACOL, QLD 4076, AUSTRALIA
TELEPHONE: [phone]
FAX NO: [phone]
E-MAIL: [e-mail]
DIRECTIONS FOR USE
Restrictions apply on the use of imidocarb in lactating
dairy cattle.
AFTER CARE
Cattle should have access to good feed, shade and water
during and after the expected reaction periods. Stress should
be avoided.
WITHHOLDING PERIOD
Nil; however, carcass quality could be affected by fever if
animals are slaughtered during vaccine reaction periods.
USER SAFETY INFORMATION
Strains of tick fever used in the Australian tick fever vaccines
are not known to be infective for humans. However, the
following people may be at increased risk after self-inject

Summary of Product characteristics

_TICK FEVER CENTRE, WACOL _
_MSDS MONO _
MATERIAL SAFETY DATA SHEET 
MONOVALENT TICK FEVER VACCINE 

_REF: MSDS 1 _
_ _
_ _
Rev: 2 
Date of Issue:  4/09/08 
Page 1 of 5 

Department of Primary Industries and Fisheries, Queensland 
Biosecurity 
Tick Fever Centre 
280 Grindle Road, Wacol  Queensland  4076  Australia 

Telephone:  [phone] 

Fax:  [phone] 
 E-mail: 

[e-mail]

Web-site: http://www.dpi.qld.gov.au/tickfever/

IDENTIFICATION 

PRODUCT NAME
: 

MONOVALENT TICK FEVER VACCINE 

OTHER NAMES: 

Monovalent chilled vaccine 

MANUFACTURER’S PRODUCT CODE
: 
MON/10, 20, 25, 50, 100. 

UN 
NUMBER: 
   None allocated 

DANGEROUS GOODS CLASS AND  
None allocated, no subsidiary risk 
SUBSIDIARY RISK 

HAZCHEM CODE: 

None allocated 

POISONS SCHEDULE NUMBER:   
Not scheduled 

USE:   

For control of Tick Fever (Bovine Babesiosis) 
by vaccination in cattle. 

PHYSICAL DESCRIPTION/PROPERTIES: 

APPEARANCE: 
   Liquid blood based vaccine packed in polypropylene  
     pillow 
packs 

BOILING 
POINT 
   No data.  Expected to be about 100
0
C 

VAPOUR PRESSURE: 

No data 

SPECIFIC GRAVITY: 

Approximately 0.97 

FLAMMABILITY:     Does not burn 

CORROSIVENESS:     Not corrosive 

_TICK FEVER CENTRE, WACOL _
_MSDS MONO _
MATERIAL SAFETY DATA SHEET 
MONOVALENT TICK FEVER VACCINE 

_REF: MSDS 1 _
_ _
_ _
Rev: 2 
Date of Issue:  4/09/08 
Page 2 of 5 

OTHER PROPERTIES: 

INGREDIENTS: 
   Contains live attenuated tick fever organisms (_Babesia bovis_) 
     in 
bovine 
blood 
diluted 
with a cell free diluent.   
The diluent consists of 10% bovine serum in an isotonic 
balanced salt solution. 

     Each 
2 
mL 
dose 
of 
monovalent vaccine contains:  

     (i) 
Bovine 
blood 
containing 

_Babesia bovis at 1 x _10
7